Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.55
|
0.63
|
0.562
|
0.562
|
0.562
|
0.562
|
|
|
|
|
0.55
|
0.662
|
0.576
|
0.576
|
0.576
|
0.576
|
|
|
|
|
0.55
|
0.654
|
0.572
|
0.572
|
0.582
|
0.582
|
|
|
|
|
0.55
|
0.65
|
0.572
|
0.572
|
0.58
|
0.58
|
|
|
|
|
|
|
0.564
|
0.564
|
0.564
|
0.564
|
|
|
|
|
0.55
|
0.618
|
0.524
|
0.524
|
0.544
|
0.544
|
|
|
|
|
0.524
|
0.64
|
0.532
|
0.532
|
0.562
|
0.534
|
|
|
|
|
0.532
|
0.65
|
0.556
|
0.554
|
0.582
|
0.554
|
|
|
|
|
0.556
|
0.68
|
0.578
|
0.578
|
0.612
|
0.592
|
|
|
177.60
|
5.00
|
0.578
|
0.706
|
0.578
|
0.578
|
0.604
|
0.592
|
|
|
|
|
BenevolentAI is a leading, clinical-stage AI drug discovery company. Through the combined capabilities of its AI platform, scientific expertise and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods.